Kyverna Therapeutics Inc. (KYTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.29
-0.04 (-1.20%)
At close: Jan 15, 2025, 3:59 PM
3.29
-0.03%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 |
PE Ratio | -334.77 | -26.79 | -29.38 |
PS Ratio | n/a | 110.19 | 136.87 |
PB Ratio | 410.94 | -10.46 | -16.74 |
P/FCF Ratio | -381.07 | -20.99 | -33.02 |
P/OCF Ratio | -385.59 | -21.44 | -34.94 |
OCF/S Ratio | n/a | -5.14 | -3.92 |
Debt / Equity Ratio | 0.18 | -0.14 | -0.12 |
Quick Ratio | 3.05 | 4.45 | 4.84 |
Current Ratio | 3.05 | 4.45 | 4.84 |
Asset Turnover | n/a | 0.10 | 0.07 |
Interest Coverage | -333.72 | -452.06 | -8.78K |
Return on Equity (ROE) | -1.23 | 0.39 | 0.57 |
Return on Assets (ROA) | -0.8 | -0.43 | -0.31 |
Return on Capital (ROIC) | -1.13 | -0.53 | -0.38 |
Dividend Yield | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a |
Gross Profit Margin | n/a | 85.04% | 89.64% |
Net Profit Margin | n/a | -411.29% | -465.88% |
Pretax Profit Margin | n/a | -411.29% | -465.88% |
Operating Profit Margin | n/a | -418.28% | -465.81% |
FCF Margin | n/a | -525% | -414.5% |
EBITDA Margin | n/a | -395.4% | -455.46% |